These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28631044)

  • 1. [Personalized treatment of viral hepatitis of the present and the future : Hepatitis B, C, delta, and E].
    Bartenschlager R; Cornberg M; Pietschmann T
    Internist (Berl); 2017 Jul; 58(7):666-674. PubMed ID: 28631044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
    Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
    Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peginterferon alfa-2a for the treatment of chronic hepatitis C in the era of direct-acting antivirals.
    Huang Y; Li MH; Hou M; Xie Y
    Hepatobiliary Pancreat Dis Int; 2017 Oct; 16(5):470-479. PubMed ID: 28992878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral hepatitis in older adults.
    Marcus EL; Tur-Kaspa R
    J Am Geriatr Soc; 1997 Jun; 45(6):755-63. PubMed ID: 9180674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
    Liu CJ; Chuang WL; Lee CM; Yu ML; Lu SN; Wu SS; Liao LY; Chen CL; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Liu CH; Su WW; Lin CL; Jeng YM; Chen PJ; Chen DS
    Gastroenterology; 2009 Feb; 136(2):496-504.e3. PubMed ID: 19084016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human immunodeficiency virus infection and viral hepatitis].
    Soriano V; Martin-Carbonero L; Vispo E; Labarga P; Barreiro P
    Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):691-701. PubMed ID: 21978797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatitis B and C in children.
    El-Shabrawi M; Hassanin F
    Minerva Pediatr; 2014 Oct; 66(5):473-89. PubMed ID: 25253190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus reactivation after effective sofosbuvir and ribavirin treatment in a patient with occult hepatitis B virus infection.
    Odolini S; Lanza P; Angiola A; Zaltron S; Urbinati L; Vavassori A; Nasta P; Festa E; Gargiulo F; Rodella A; Caruso A; Casari S; Castelli F; Viganò M
    New Microbiol; 2017 Jul; 40(3):218-220. PubMed ID: 28513813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral therapies for managing viral hepatitis in lymphoma patients.
    Merli M; Rattotti S; Gotti M; Arcaini L
    Expert Opin Pharmacother; 2017 Mar; 18(4):363-376. PubMed ID: 28140702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV.
    Liu CJ; Chuang WL; Sheen IS; Wang HY; Chen CY; Tseng KC; Chang TT; Massetto B; Yang JC; Yun C; Knox SJ; Osinusi A; Camus G; Jiang D; Brainard DM; McHutchison JG; Hu TH; Hsu YC; Lo GH; Chu CJ; Chen JJ; Peng CY; Chien RN; Chen PJ
    Gastroenterology; 2018 Mar; 154(4):989-997. PubMed ID: 29174546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral hepatitis in solid organ transplantation other than liver.
    Vallet-Pichard A; Fontaine H; Mallet V; Pol S
    J Hepatol; 2011 Aug; 55(2):474-82. PubMed ID: 21241754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis A, B, C, D, E - What treatment options for whom?].
    Manns M
    Drug Res (Stuttg); 2014 Nov; 64 Suppl 1():S18-9. PubMed ID: 25423421
    [No Abstract]   [Full Text] [Related]  

  • 13. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
    Vallet-Pichard A; Pol S
    Nephrol Ther; 2015 Nov; 11(6):507-20. PubMed ID: 26423779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
    Bonifati C; Lora V; Graceffa D; Nosotti L
    World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on dual hepatitis B and C infection in Taiwan.
    Liu CJ; Chen PJ; Chen DS; Tseng TC; Kao JH
    J Formos Med Assoc; 2016 May; 115(5):298-305. PubMed ID: 26188762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of viral hepatitis in liver transplant recipients.
    Jeong SW; Choi Y; Kim JW
    Clin Mol Hepatol; 2014 Dec; 20(4):338-44. PubMed ID: 25548738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
    Yu ML; Lee CM; Chen CL; Chuang WL; Lu SN; Liu CH; Wu SS; Liao LY; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Su WW; Lin CL; Yang HC; Chen PJ; Chen DS; Liu CJ;
    Hepatology; 2013 Jun; 57(6):2135-42. PubMed ID: 23322699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.
    Liu CJ
    J Gastroenterol Hepatol; 2014 Jan; 29(1):26-30. PubMed ID: 24199625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
    Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL
    J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From non-A, non-B hepatitis to hepatitis C virus cure.
    Pawlotsky JM; Feld JJ; Zeuzem S; Hoofnagle JH
    J Hepatol; 2015 Apr; 62(1 Suppl):S87-99. PubMed ID: 25920094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.